Ashmitha Rajendran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ashmitha Rajendran has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Leyre Merino-Galan
Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children’s Research Institute, Seattle, WA, United States of America
2 shared publications- Siobhan S. Pattwell
Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children’s Research Institute, Seattle, WA, United States of America
2 shared publications - Sonali Arora
Human Biology Division, Fred Hutchinson Cancer Center, Seattle, USA
2 shared publications David Johnson
Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children’s Research Institute, Seattle, WA
1 shared publicationEric C. Holland
Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America
1 shared publicationGregory Glatzer
Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America
1 shared publication
Latest Publications
- Open Access
Transcriptomic analysis reveals differential regulation of synaptic components in pediatric and adult brain tumors
Neuronal-cancer cell interactions are a key component of brain tumor pathophysiology, yet many fundamental questions remain unanswered – with even more remaining unasked. Here, we present a comprehensive brain tumor reference map generated from bulk RNA-seq data of ∼4,300 adult and pediatric brain tumors—including various glioma subtypes, medulloblastomas, ependymomas, and meningiomas—alongside ∼1,400 healthy brain samples. By analyzing synaptic processes and synaptic gene expression across tumor types, we reveal the complexity of neuron-tumor crosstalk and its potential impact on patient survival. Our findings identify key synaptic signaling pathways and dysregulated patterns in brain tumors, including HNRNPH2 upregulation, a key factor in RNA processing and metabolism, in gliomas and medulloblastomas. Additionally, we highlight the role of cholinergic signaling, particularly CHRNA9 , as a driver of glioma progression, which is also upregulated in WNT and Group 4 medulloblastomas, ependymomas, and meningiomas. Furthermore, P2 purinergic signaling emerges as a key player in glioma progression. These insights lay the groundwork for future studies exploring whether targeting these pathways could reprogram the tumor microenvironment toward an anti-tumor state, ultimately leading to novel therapeutic strategies and improved patient outcomes. Highlights: A comprehensive brain tumor reference map was generated using bulk RNA-seq from ∼4,300 adult and pediatric brain tumors and ∼1,400 healthy brain samples. HNRNPH2 is consistently upregulated across all adult and pediatric gliomas, as well as all medulloblastoma subgroups. Nicotinic acetylcholine receptors (nAChRs) are upregulated in glioblastomas and pediatric high-grade gliomas but downregulated in low-grade gliomas, underscoring their role in glioma aggressiveness. CHRNA9 is a key driver of glioma progression and is also upregulated in medulloblastomas (WNT and Group 4), ependymomas, and meningiomas Graphical
Open AccessTranscriptomic analysis reveals differential regulation of synaptic components in pediatric and adult brain tumors
Neuronal-cancer cell interactions are a key component of brain tumor pathophysiology, yet many fundamental questions remain unanswered – with even more remaining unasked. Here, we present a comprehensive brain tumor reference map generated from bulk RNA-seq data of ∼4,300 adult and pediatric brain tumors—including various glioma subtypes, medulloblastomas, ependymomas, and meningiomas—alongside ∼1,400 healthy brain samples. By analyzing synaptic processes and synaptic gene expression across tumor types, we reveal the complexity of neuron-tumor crosstalk and its potential impact on patient survival. Our findings identify key synaptic signaling pathways and dysregulated patterns in brain tumors, including HNRNPH2 upregulation, a key factor in RNA processing and metabolism, in gliomas and medulloblastomas. Additionally, we highlight the role of cholinergic signaling, particularly CHRNA9 , as a driver of glioma progression, which is also upregulated in WNT and Group 4 medulloblastomas, ependymomas, and meningiomas. Furthermore, P2 purinergic signaling emerges as a key player in glioma progression. These insights lay the groundwork for future studies exploring whether targeting these pathways could reprogram the tumor microenvironment toward an anti-tumor state, ultimately leading to novel therapeutic strategies and improved patient outcomes. Highlights: A comprehensive brain tumor reference map was generated using bulk RNA-seq from ∼4,300 adult and pediatric brain tumors and ∼1,400 healthy brain samples. HNRNPH2 is consistently upregulated across all adult and pediatric gliomas, as well as all medulloblastoma subgroups. Nicotinic acetylcholine receptors (nAChRs) are upregulated in glioblastomas and pediatric high-grade gliomas but downregulated in low-grade gliomas, underscoring their role in glioma aggressiveness. CHRNA9 is a key driver of glioma progression and is also upregulated in medulloblastomas (WNT and Group 4), ependymomas, and meningiomas Graphical
- Open Access
Transferable Transcriptional Topic Modeling Traces Medulloblastoma Subtypes to Distinct Cerebellar Developmental States
SUMMARY: Single-cell transcriptomics transformed our understanding of cellular heterogeneity, yet cross-dataset comparison remains fundamentally limited by batch effects, technology differences, and inconsistent annotation frameworks. These challenges have impeded efforts to connect developmental programs with disease states which creates a critical gap for understanding pediatric cancers with suspected developmental origins. Here, we demonstrate that topic modeling, an unsupervised natural language processing technique, overcomes these barriers by learning transferable transcriptional genetic signatures that generalize across datasets, technologies, and biological contexts without requiring data integration. Applying this framework to over one million fetal cerebellar nuclei, we identify seven distinct topics that capture the developmental spectrum of rhombic lip progenitors through external granule layer (EGL) differentiation, including transitional states missed by conventional clustering. These topics transfer successfully across sequencing technologies (SPLiT-seq to sci-RNA-seq3), developmental timepoints, species (human to mouse), and from single-cell to bulk RNA sequencing of 876 medulloblastoma tumors. We reveal that Sonic hedgehog (SHH) medulloblastoma subtypes retain these topics, corresponding to distinct stages of EGL development. Our findings highlight that developmental timing at tumor initiation fundamentally shapes tumor biology, with immediate implications for subtype-specific therapeutic strategies in pediatric brain cancer. Our workflow establishes topic modeling as a scalable solution for mining expanding genomic atlases with broad applications across different datasets, technologies, and biological contexts.
Open AccessTransferable Transcriptional Topic Modeling Traces Medulloblastoma Subtypes to Distinct Cerebellar Developmental States
SUMMARY: Single-cell transcriptomics transformed our understanding of cellular heterogeneity, yet cross-dataset comparison remains fundamentally limited by batch effects, technology differences, and inconsistent annotation frameworks. These challenges have impeded efforts to connect developmental programs with disease states which creates a critical gap for understanding pediatric cancers with suspected developmental origins. Here, we demonstrate that topic modeling, an unsupervised natural language processing technique, overcomes these barriers by learning transferable transcriptional genetic signatures that generalize across datasets, technologies, and biological contexts without requiring data integration. Applying this framework to over one million fetal cerebellar nuclei, we identify seven distinct topics that capture the developmental spectrum of rhombic lip progenitors through external granule layer (EGL) differentiation, including transitional states missed by conventional clustering. These topics transfer successfully across sequencing technologies (SPLiT-seq to sci-RNA-seq3), developmental timepoints, species (human to mouse), and from single-cell to bulk RNA sequencing of 876 medulloblastoma tumors. We reveal that Sonic hedgehog (SHH) medulloblastoma subtypes retain these topics, corresponding to distinct stages of EGL development. Our findings highlight that developmental timing at tumor initiation fundamentally shapes tumor biology, with immediate implications for subtype-specific therapeutic strategies in pediatric brain cancer. Our workflow establishes topic modeling as a scalable solution for mining expanding genomic atlases with broad applications across different datasets, technologies, and biological contexts.